Gut Microbiome in Depression with and without REM Sleep Behavior Disorder
Major depressive disorder (MDD) is a risk factor for neurodegeneration, yet its heterogeneity makes identifying at-risk subtype challenging. Notably, MDD frequently co-occurs with REM sleep behavior disorder (RBD), a specific prodrome of α-synucleinopathy. It remains unclear whether comorbid MDD + RBD reflects a benign antidepressant effect, or higher neurodegenerative risk. Given growing recognition of gut-brain axis in neuropsychiatry, we aimed to delineate microbial signatures of MDD + RBD. We employed a four-group case-control design (N = 420) comprising 124 healthy controls (HC); 80 MDD without RBD features (MDD-only); 82 MDD + RBD; and 134 iRBD without psychiatric disease. All participants underwent clinical evaluation and provided fecal samples for metagenomic sequencing. Random Forest model was used to distinguish MDD + RBD, and further assessed in a validation dataset of 65 participants with MDD + RBD (n = 31) and MDD-only (n = 34). MDD + RBD exhibited prodromal neurodegenerative features, including elevated total likelihood ratio of prodromal Parkinson's Disease, olfactory deficits, and subtle motor signs. The microbial composition in MDD + RBD differed from HC and MDD-only, while resembling iRBD. Taxonomically, MDD + RBD exhibited an iRBD-like dysbiosis (e.g., enriched Akkermansia muciniphila, Ruthenibacterium lactatiformans; depleted Faecalibacterium prausnitzii), alongside depression-associated shifts (e.g., Streptococcus parasanguinis and Actinomyces oris). Functionally, MDD + RBD showed attenuated capacity of B‑vitamin biosynthesis and polysaccharides degradation, mirroring iRBD. The Random Forest machine-learning model distinguished MDD + RBD in older adults from MDD-only with an AUC of 0.73 in cross-validation and 0.79 in the validation dataset. MDD + RBD may represent a biologically distinct depression subtype associated with potential neurodegenerative risk. Gut microbiome provides a candidate approach for potential risk stratification in psychiatric populations.
Authors
- Brian P. N. Or (ORCID: https://orcid.org/0009-0009-7364-9971)
- Li Zhou
- Filip Scheperjans (ORCID: https://orcid.org/0000-0001-9502-7131)
- Steven Wai Ho Chau (ORCID: https://orcid.org/0000-0002-2986-8677)
- Siyi Gong (ORCID: https://orcid.org/0000-0001-7994-9734)
- Christopher K.C. Lai (ORCID: https://orcid.org/0000-0001-8591-5944)
- Yuhua Yang (ORCID: https://orcid.org/0000-0001-5590-8348)
- Vincent Mok (ORCID: https://orcid.org/0000-0002-8102-8835)
- Shi Tang
- Yun Kwok Wing (ORCID: https://orcid.org/0000-0002-5745-5474)
- Jing Wang (ORCID: https://orcid.org/0000-0002-9906-8712)
- Paul K.S. Chan (ORCID: https://orcid.org/0000-0002-6360-4608)
- Z Chen
- Ningning Li (ORCID: https://orcid.org/0000-0002-0414-5878)
- Jihui Zhang (ORCID: https://orcid.org/0000-0002-4976-3039)
- Yaping Liu (ORCID: https://orcid.org/0000-0002-2015-8775)
- Joey Wing Yan Chan (ORCID: https://orcid.org/0000-0002-2692-2666)
- Jianzhang Ni
- Sunny H. Wong
- Bei Huang
- Siu Ping Lam
- Ngan Yin Chan
- Zhixuan He
Institutions
- University of Helsinki (FI)
- Nanyang Technological University (SG)
- Chinese University of Hong Kong (HK)
- Helsinki University Hospital (FI)
- Key Laboratory of Guangdong Province (CN)
- Guangdong 999 Brain Hospital (CN)
- Guangzhou Medical University (CN)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Molecular Psychiatry
- Published
- 2026-07-23
- DOI
- https://doi.org/10.1038/s41380-026-03773-3
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Research Grants Council, University Grants Committee
- Food and Health Bureau
- Health and Medical Research Fund